Ting Lin

Changsha, 410208, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Yiqi Jiedu Formula inhibits proliferation, invasion and migration of nasopharyngeal carcinoma cells by inhibiting the AKT1/GLUT1 signaling pathway

Yiqi Jiedu Formula inhibits proliferation, invasion and migration of nasopharyngeal carcinoma cells by inhibiting the AKT1/GLUT1 signaling pathway

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: February 03, 2026

Retraction Note: Identification of RNA processing factor LSM5 as a new adverse biomarker in nasopharyngeal carcinoma.

Retraction Note: Identification of RNA processing factor LSM5 as a new adverse biomarker in nasopharyngeal carcinoma.

Journal: Scientific reports

Published: September 30, 2025

The microbial conductor of cancer hallmarks: intratumoral microbiome as a multidimensional oncogenic modulator.

The microbial conductor of cancer hallmarks: intratumoral microbiome as a multidimensional oncogenic modulator.

Journal: Frontiers in microbiology

Published: September 01, 2025

A review on the role of IL-6 in the onset and progression of nasopharyngeal carcinoma.

A review on the role of IL-6 in the onset and progression of nasopharyngeal carcinoma.

Journal: Medical oncology (Northwood, London, England)

Published: July 14, 2025

Effect of Biyan Jiedu Capsules on proliferation and apoptosis of nasopharyngeal carcinoma cells based on PI3K/Akt pathway

Effect of Biyan Jiedu Capsules on proliferation and apoptosis of nasopharyngeal carcinoma cells based on PI3K/Akt pathway

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: May 12, 2025

Clinical implications of miR-195 in cancer: mechanisms, potential applications, and therapeutic strategies.

Clinical implications of miR-195 in cancer: mechanisms, potential applications, and therapeutic strategies.

Journal: Journal of cancer research and clinical oncology

Published: February 04, 2025

Homoharringtonine: mechanisms, clinical applications and research progress.

Homoharringtonine: mechanisms, clinical applications and research progress.

Journal: Frontiers in oncology

Published: November 04, 2024

Identification of RNA processing factor LSM5 as a new adverse biomarker in nasopharyngeal carcinoma.

Identification of RNA processing factor LSM5 as a new adverse biomarker in nasopharyngeal carcinoma.

Journal: Scientific reports

Published: September 27, 2024

Global trends in research of nasopharyngeal carcinoma: a bibliometric and visualization analysis.

Global trends in research of nasopharyngeal carcinoma: a bibliometric and visualization analysis.

Journal: Frontiers in oncology

Published: February 27, 2024

Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking.

Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking.

Journal: Medicine

Published: December 05, 2023

Unraveling the mechanism of Yiqi Jiedu formula against nasopharyngeal carcinoma: An investigation integrating network pharmacology, serum pharmacochemistry, and metabolomics.

Unraveling the mechanism of Yiqi Jiedu formula against nasopharyngeal carcinoma: An investigation integrating network pharmacology, serum pharmacochemistry, and metabolomics.

Journal: Journal of ethnopharmacology

Published: August 31, 2023

MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.

MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.

Journal: American journal of cancer research

Published: May 08, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026